GorillaHead
Member
![www.ncbi.nlm.nih.gov](/community/proxy.php?image=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fcorehtml%2Fpmc%2Fpmcgifs%2Fpmc-logo-share.png%3F_%3D0&hash=504c5fc52fbb2b7e56faaa53c7cb9bd1&return_error=1)
Teneligliptin-induced hair loss: A case report
Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the common phenotype of hyperglycemia secondary to various pathophysiologic mechanisms that include reduced insulin secretion, decreased glucose utilization, and increased ...
![www.ncbi.nlm.nih.gov](/community/proxy.php?image=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fcoreutils%2Fnwds%2Fimg%2Ffavicons%2Ffavicon.png&hash=78667591a96ab09efe3eb2c1bcac7c98&return_error=1)
If this study is to be trusted. Then we just made a huge leap in understanding male pattern baldness.
MPB is almost certainly related to insulin without a doubt as both genes related to insulin have been implicated. and conditions such as myotonic dytrophy highly correlated to mpb and also have insulin related pathology.
I will need to spend more time to understand if increasing dpp-4 is the simple solution to stopping the hairloss or if the drug does more than just inhibit dpp-4.
This is is exciting.